Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page
- Check4 days agoChange DetectedThe page's revision metadata was updated from v3.6.4 to v3.6.5. This indicates a backend/template update rather than any modification to study content or user-facing information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor backend/software update to the page. No study content or patient-facing information is altered by this change.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates the page has been updated to a newer version without altering study details or functionality.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter revision updated from v3.6.0 to v3.6.2. This indicates a minor site version bump; no substantive content changes in the study details.SummaryDifference0.1%

- Check62 days agoChange DetectedNew help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note states No longer looking for participants. The Intervention/Treatment heading formatting was adjusted and the revision updated to v3.6.0.SummaryDifference0.4%

- Check69 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor behind-the-scenes update to the page template or system release.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.